Enforcement

Subscribe to Enforcement

Prop 12 Enforcement Delayed for Some Stakeholders

Posted on January 26, 2022

On January 24, Judge James P. Arguelles for the Superior Court in Sacramento County ordered an enforcement delay of a part of California’s Proposition 12. Judge Arguelles ruled that grocers,

…
Continue Reading Prop 12 Enforcement Delayed for Some Stakeholders

FDA Increases FSVP Enforcement

Posted on April 24, 2020

FDA appears to have stepped up its enforcement of Foreign Supplier Verification (FSVP) regulations in the past several weeks, issuing four warning letters to companies in the past month for

…
Continue Reading FDA Increases FSVP Enforcement

FDA Issues Warning Letter for Fraudulent COVID-19 Treatment Product

Posted on April 10, 2020

FDA has issued warning letters to companies selling allegedly fraudulent products with claims to prevent, cure, treat, or diagnose COVID-19. Companies that sell products with unapproved claims regarding COVID-19 may

…
Continue Reading FDA Issues Warning Letter for Fraudulent COVID-19 Treatment Product

FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD

Posted on October 23, 2019

On October 10, the FDA and FTC sent a joint warning letter to Rooted Apothecary LLC for illegally selling unapproved drug products containing cannabidiol (CBD) online with unsubstantiated claims that

…
Continue Reading FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD

Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

Posted on September 19, 2019

Senate Majority Leader Mitch McConnell (R-KY) has introduced language into a Senate appropriations bill that would require FDA to issue temporary guidance on enforcement related to products containing cannabidiol (CBD).

…
Continue Reading Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

FDA Takes New Steps to Curtail Youth Access to Tobacco Products and E-Cigarettes

Posted on March 5, 2019

The U.S. Food and Drug Administration (FDA) announced several new steps it is taking to combat youth access to tobacco products and e-cigarettes. In a March 4 statement, FDA

…
Continue Reading FDA Takes New Steps to Curtail Youth Access to Tobacco Products and E-Cigarettes

Menu Labeling Update: FDA Releases Supplemental Draft Guidance

Posted on November 8, 2017

Over the past several years, FDA has been in the process of implementing menu labeling provisions added to the Federal Food, Drug, and Cosmetic Act by the Affordable Care Act.

…
Continue Reading Menu Labeling Update: FDA Releases Supplemental Draft Guidance

FDA Formally Extends Menu Labeling Compliance Date to 2018

Posted on May 2, 2017

As covered on this blog last week, on April 26, 2017, the FDA submitted an interim final rule (IFR) to the Office of Management and Budget (OMB) seeking an

…
Continue Reading FDA Formally Extends Menu Labeling Compliance Date to 2018